Ligand profile
CXB
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0891 — beta-lactamase SHV-24
Identifiers
Database identifiers and provenance.
- Ligand ID
CXB- PDB
1nym- UniProt (similar protein)
P62593- Target protein
- VK055_0891
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 130.1
- −1 ≤ LogP ≤ 5 -1.80
- MW ≤ 500 Da 258.1
- LogP ≤ 5 -1.80
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 130.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B(CNC(=O)/C(=N\OC)/c1csc(n1)N)(O)OB(CNC(=O)/C(=N\OC)/c1csc(n1)N)(O)O
InChI=1S/C7H11BN4O4S/c1-16-12-5(4-2-17-7(9)11-4)6(13)10-3-8(14)15/h2,14-15H,3H2,1H3,(H2,9,11)(H,10,13)/b12-5-InChI=1S/C7H11BN4O4S/c1-16-12-5(4-2-17-7(9)11-4)6(13)10-3-8(14)15/h2,14-15H,3H2,1H3,(H2,9,11)(H,10,13)/b12-5-
FMYGJTQJYFMFCR-XGICHPGQSA-NFMYGJTQJYFMFCR-XGICHPGQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CXB →
- PDB RCSB structure 1nym →
- UniProt UniProt P62593 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CXB”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0891.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).